|
|
 |
LETTER TO EDITOR |
|
Year : 2012 | Volume
: 28
| Issue : 4 | Page : 546-547 |
|
Mannitol-induced intraoperative hyperkalemia, a little-known clinical entity
JP Sharma, Rashmi Salhotra
Dept of Anaesthesiology and Critical Care,UCMS and GTB Hospital, Delhi, India
Date of Web Publication | 4-Oct-2012 |
Correspondence Address: Rashmi Salhotra 18/30, First Floor, Shakti Nagar, Delhi 110007 India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0970-9185.101965
How to cite this article: Sharma J P, Salhotra R. Mannitol-induced intraoperative hyperkalemia, a little-known clinical entity. J Anaesthesiol Clin Pharmacol 2012;28:546-7 |
How to cite this URL: Sharma J P, Salhotra R. Mannitol-induced intraoperative hyperkalemia, a little-known clinical entity. J Anaesthesiol Clin Pharmacol [serial online] 2012 [cited 2021 Jan 18];28:546-7. Available from: https://www.joacp.org/text.asp?2012/28/4/546/101965 |
Sir,
Mannitol is commonly used in neuroanesthesia as a hypertonic infusion to reduce intracranial pressure and volume. However, its use can lead to serious electrolyte abnormalities. We report a case of a 23-year-old man, who received 1.5 g/kg mannitol over 20 min during excision of cerebellar hemangioblastoma. After 30 min from the start of mannitol infusion, electrocardiogram (ECG) showed tall T-waves with QRS widening. Arterial blood gas (ABG) and electrolyte analysis was immediately done and 100% oxygen was delivered. Ten milliliters of 10% calcium gluconate intravenous (IV) was administered slowly over 10 min. Tall T-waves persisted. Arterial Blood Gas picture showed pO 2 = 207, pCO 2 = 29.2, pH = 7.32, and K + = 9.0 mEq/l. An IV infusion of 20 units insulin in 10% dextrose (GI) was started. Repeat serum K + after 30 min was 6.9 mEq/l. The same therapy was continued and furosemide 20 mg was also given. Serum K + at 1 h and 1 h 45 min was 5.3 mEq/l and 4.1 mEq/l, respectively. ECG changes reverted to normal after 50 min of therapy with GI infusion. No acidosis was found at any time. The rest of the intraoperative course was uneventful, and the patient was observed in the intensive care unit for 24 h.
Mannitol 20% (osmolality approximately 1100 mOs/l) is given intraoperatively to reduce the intracranial and intraocular pressure, to preserve renal function and urine output in acute renal failure, and to reduce cerebral edema before and after neurosurgery. It should be used with caution in patients with deranged renal functions and should be infused slowly over a period of 20-30 min, avoiding extravasations and under proper cardiovascular and renal function monitoring. Mannitol in high doses (2 g/kg) is known to cause a significant increase in serum K + levels, while low doses (1 g/kg) are known to cause hypokalemia. [1] Hyperkalemia may be due to an expansion in extracellular fluid (ECF) volume leading to dilution of bicarbonate and hence dilutional acidosis, RBC crenation leading to hemolysis, and solvent drag phenomena causing shift of intracellular K + -rich fluid to the ECF compartment to maintain the tonicity. [1] The strong ion difference (SID) theory may also have a role. [2]
Life-threatening increase in serum K + level has been previously reported in literature while administering mannitol for reducing the intracranial pressure. [3] Mannitol-induced acute high serum levels of potassium can also lead to life-threatening ventricular tachycardia, [4] with or without severe metabolic acidosis. [5]
Mannitol should be used in low doses (0.75-1 g/kg) under continuous ECG monitoring, keeping in mind the electrolyte disturbances that the administration of mannitol can entail. Frequent monitoring of electrolytes and acid-base status is recommended.
References | |  |
1. | Manninen PH, Lam AM, Gelb AW, Brown SC. The effect of high dose mannitol on serum and urine electrolytes and osmolality in neurosurgical patients. Can J Anaesth 1987;34:442-6.  [PUBMED] |
2. | Stewart PA. Modern quantitative acid-base chemistry. Can J Physiol Pharmacol 1983;61:1444-61.  [PUBMED] |
3. | Hassan ZU, Kruer JJ, Furhman TM. Electrolyte changes during craniotomy caused by administration of hypertonic mannitol. J Clin Anesth 2007;19:307-9.  |
4. | Seto A, Murakami M, Fukuyama H, Niijima K, Aoyama K, Takenaka I, et al. Ventricular tachycardia caused by hyperkalemia after administration of hypertonic mannitol. Anesthesiology 2000;93:1359-61.  [PUBMED] |
5. | Kimura S, Ogawa H, Katayama Y. Hyperkalemia caused by intravenous administration of mannitol in a patient with arteriovenous malformation: Case report. No Shinkei Geka 2006;34:51-6.  [PUBMED] |
This article has been cited by | 1 |
Comparison of the effects of 7.2% hypertonic saline and 20% mannitol on electrolyte and acid-base variables in dogs with suspected intracranial hypertension |
|
| Sabrina N. Hoehne,Ivayla D. Yozova,Beatriz Vidondo,Katja N. Adamik | | Journal of Veterinary Internal Medicine. 2020; | | [Pubmed] | [DOI] | | 2 |
Trastornos electrolíticos inducidos por fármacos y sustancias tóxicas |
|
| Edna Chinchilla-Escobar,Edna Héctor Pérez-Madrid,Laura Jiménez-Ospina,Diana Cabrera-Rojas,Natalia Palacín-Bernal,Germán Sepúlveda-Barbosa,Juan D. Piedrahita-Pérez,Luisa F. Díaz-Vélez,Juliana Quintero-Aguirre,María A. Montoya-Giraldo | | Medicina y Laboratorio. 2020; 25(1): 363 | | [Pubmed] | [DOI] | | 3 |
Life-Threatening Mannitol-Induced Hyperkalemia in Neurosurgical Patients |
|
| Andrew A. Fanous,Robert C. Tick,Eugene Y. Gu,Robert A. Fenstermaker | | World Neurosurgery. 2016; | | [Pubmed] | [DOI] | | 4 |
Postoperative hyperkalemia |
|
| Taha Ayach,Robert W. Nappo,Jennifer L. Paugh-Miller,Edward A. Ross | | European Journal of Internal Medicine. 2015; | | [Pubmed] | [DOI] | | 5 |
Drug-Induced Hyperkalemia |
|
| Chaker Ben Salem,Atef Badreddine,Neila Fathallah,Raoudha Slim,Houssem Hmouda | | Drug Safety. 2014; | | [Pubmed] | [DOI] | | 6 |
Mannitol |
|
| | | Reactions Weekly. 2013; 1434(1): 43 | | [Pubmed] | [DOI] | | 7 |
Acute hyperkalemia and hyponatremia following intraoperative mannitol administration |
|
| Rimal, J. and Pisklakov, S.V. and Boules, H. and Patel, A. | | Journal of Anesthesia and Clinical Research. 2013; 4(3) | | [Pubmed] | |
|
 |
 |
|